Literature DB >> 16563479

Trends in colon cancer screening procedures in the US Medicare and Tricare populations: 1999-2001.

Randal H Robertson1, Jeffrey H Burkhardt, M Paige Powell, Mohamad A Eloubeidi, Maria Pisu, Norman W Weissman.   

Abstract

BACKGROUND: This study examined trends in the numbers of double contrast barium enemas, flexible sigmoidoscopies, and colonoscopies and trends in the choices of colorectal cancer screening service providers.
METHODS: Descriptive statistics were used to examine Medicare and Tricare data for the years 1999 to 2001.
RESULTS: The total volume of procedures increased 5% and 14%, respectively, in Tricare and Medicare. Tricare and Medicare, respectively, saw 32% and 33% reductions in barium enemas and 28% and 41% reductions in flexible sigmoidoscopies. Colonoscopies increased by 45% and 34% in Tricare and Medicare, respectively. Gastroenterologists provided the majority of colonoscopies for both groups each year.
CONCLUSIONS: The volume of colonoscopies increased from 1999 to 2001 for both groups while the volumes of barium enemas and flexible sigmoidoscopies decreased. Gastroenterologists appear to be the preferred providers of colonoscopies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16563479     DOI: 10.1016/j.ypmed.2006.01.014

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  10 in total

1.  Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.

Authors:  Amy B Knudsen; Iris Lansdorp-Vogelaar; Carolyn M Rutter; James E Savarino; Marjolein van Ballegooijen; Karen M Kuntz; Ann G Zauber
Journal:  J Natl Cancer Inst       Date:  2010-07-27       Impact factor: 13.506

2.  Overuse of colonoscopy for colorectal cancer screening and surveillance.

Authors:  Gina R Kruse; Sami M Khan; Alan M Zaslavsky; John Z Ayanian; Thomas D Sequist
Journal:  J Gen Intern Med       Date:  2014-09-30       Impact factor: 5.128

3.  Proximal and distal colorectal cancer resection rates in the United States since widespread screening by colonoscopy.

Authors:  Parvathi A Myer; Ajitha Mannalithara; Gurkirpal Singh; Uri Ladabaum
Journal:  Gastroenterology       Date:  2012-07-27       Impact factor: 22.682

4.  Past, present and future of colorectal cancer in the Kingdom of Saudi Arabia.

Authors:  Ezzeldin M Ibrahim; Ahmed A Zeeneldin; Tawfik R El-Khodary; Aboelkhair M Al-Gahmi; Bakr M Bin Sadiq
Journal:  Saudi J Gastroenterol       Date:  2008-10       Impact factor: 2.485

5.  Trends in colorectal cancer screening utilization among ethnic groups in California: are we closing the gap?

Authors:  Annette E Maxwell; Catherine M Crespi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03       Impact factor: 4.254

6.  Characterization of forces applied by endoscopists during colonoscopy by using a wireless colonoscopy force monitor.

Authors:  Louis Y Korman; Vladimir Egorov; Sergey Tsuryupa; Brendan Corbin; Mary Anderson; Noune Sarvazyan; Armen Sarvazyan
Journal:  Gastrointest Endosc       Date:  2009-11-17       Impact factor: 9.427

7.  Utilization of upper endoscopy for surveillance of gastric ulcers in the United States.

Authors:  Sameer D Saini; Glenn Eisen; Nora Mattek; Philip Schoenfeld
Journal:  Am J Gastroenterol       Date:  2008-08       Impact factor: 10.864

8.  Prospective Study of the Quality of Colonoscopies Performed by Primary Care Physicians: The Alberta Primary Care Endoscopy (APC-Endo) Study.

Authors:  Michael R Kolber; Clarence K W Wong; Richard N Fedorak; Brian H Rowe
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

Review 9.  Status of barium studies in the present era of oncology: Are they a history?

Authors:  Abhishek Mahajan; Subash Desai; Nilesh Pandurang Sable; Meenakshi Haresh Thakur
Journal:  Indian J Med Paediatr Oncol       Date:  2016 Oct-Dec

10.  Policy of screening for colorectal cancer in Saudi Arabia: A prospective analysis.

Authors:  Abdulrahman A Aljumah; Abdulrahman M Aljebreen
Journal:  Saudi J Gastroenterol       Date:  2017 May-Jun       Impact factor: 2.485

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.